|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 164.80 CHF | 0.00% |
|
-0.36% | +5.37% |
| Dec. 10 | OssDsign Names CEO to Join January 2026 | MT |
| 25-10-10 | Berenberg Raises Medacta Price Target Amid Strong Earnings Momentum | MT |
Company Valuation: Medacta Group SA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,614 | 2,743 | 2,082 | 2,693 | 2,260 | 3,542 | 3,542 | - |
| Change | - | 70.02% | -24.1% | 29.33% | -16.08% | 56.74% | 0% | - |
| Enterprise Value (EV) 1 | 1,697 | 2,809 | 2,194 | 2,828 | 2,418 | 3,743 | 3,735 | 3,687 |
| Change | - | 65.52% | -21.89% | 28.91% | -14.51% | 54.82% | -0.24% | -1.26% |
| P/E ratio | 43.6x | 53.2x | 45.1x | 56.9x | 31x | 37.2x | 34x | 29.3x |
| PBR | 9.8x | 12.1x | 7.57x | 8.15x | 5.95x | 7.52x | 6.35x | 5.44x |
| PEG | - | 1.3x | -4.3x | 21.91x | 0.6x | 1.2x | 3.62x | 1.8x |
| Capitalization / Revenue | 5.33x | 7.56x | 4.76x | 5.27x | 3.83x | 5.14x | 4.56x | 4.09x |
| EV / Revenue | 5.61x | 7.73x | 5.02x | 5.54x | 4.09x | 5.43x | 4.81x | 4.25x |
| EV / EBITDA | 19.3x | 26.2x | 18.2x | 21.3x | 15.4x | 19.8x | 17.4x | 15.1x |
| EV / EBIT | 33.2x | 42.1x | 31.8x | 37.4x | 25.6x | 32.9x | 28.6x | 24.2x |
| EV / FCF | 66.8x | 371x | 102x | 424x | 93.3x | 123x | 79.8x | 60.3x |
| FCF Yield | 1.5% | 0.27% | 0.98% | 0.24% | 1.07% | 0.81% | 1.25% | 1.66% |
| Dividend per Share 2 | - | 0.54 | 0.54 | 0.5726 | 0.7239 | 0.841 | 0.9595 | 1.159 |
| Rate of return | - | 0.39% | 0.52% | 0.42% | 0.64% | 0.47% | 0.54% | 0.65% |
| EPS 2 | 1.85 | 2.58 | 2.31 | 2.37 | 3.65 | 4.781 | 5.23 | 6.066 |
| Distribution rate | - | 20.9% | 23.4% | 24.2% | 19.8% | 17.6% | 18.3% | 19.1% |
| Net sales 1 | 302.5 | 363.1 | 437.1 | 510.8 | 590.6 | 688.9 | 776.7 | 866.8 |
| EBITDA 1 | 88.1 | 107.1 | 120.4 | 132.9 | 156.6 | 189.1 | 214.9 | 244.9 |
| EBIT 1 | 51.08 | 66.68 | 68.94 | 75.72 | 94.37 | 113.9 | 130.4 | 152.2 |
| Net income 1 | 37.1 | 51.52 | 46.25 | 47.36 | 72.89 | 95.25 | 104.3 | 121 |
| Net Debt 1 | 83.3 | 65.27 | 111.6 | 135.2 | 157.9 | 201.1 | 192.1 | 145.1 |
| Reference price 2 | 80.68 | 137.19 | 104.23 | 134.94 | 113.27 | 177.61 | 177.61 | 177.61 |
| Nbr of stocks (in thousands) | 20,000 | 19,997 | 19,979 | 19,958 | 19,952 | 19,945 | 19,945 | - |
| Announcement Date | 3/30/21 | 3/11/22 | 3/17/23 | 3/13/24 | 3/25/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 37.03x | 5.42x | 19.73x | 0.48% | 4.1B | ||
| 30.62x | 4.82x | 18.12x | 1.95% | 212B | ||
| 22.3x | 4.1x | 14.66x | 2.93% | 124B | ||
| 24.92x | 0.21x | 13.61x | 0.64% | 68.84B | ||
| 30.94x | 3.32x | 11.38x | 1.98% | 59.01B | ||
| 38.47x | 8.74x | 24.28x | 1% | 54.23B | ||
| 33.66x | 5.87x | 20.18x | -.--% | 27.12B | ||
| 33.04x | 4.66x | 16.84x | 0.91% | 26.37B | ||
| 64.48x | 7.69x | 24.86x | 0.38% | 24.07B | ||
| Average | 35.05x | 4.98x | 18.19x | 1.14% | 66.61B | |
| Weighted average by Cap. | 30.63x | 4.51x | 17.10x | 1.71% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- MOVE Stock
- Valuation Medacta Group SA
Select your edition
All financial news and data tailored to specific country editions
















